β-Lactamase inhibition profile of new amidine-substituted diazabicyclooctanes
Authors:
Open Access
- 12 March 2021
- journal article
- research article
- Published by Beilstein Institut in Beilstein Journal of Organic Chemistry
- Vol. 17 (1) , 711-718
Abstract
The diazabicyclooctane (DBO) scaffold is the backbone of non-β-lactam-based second generation β-lactamase inhibitors. As part of our efforts, we have synthesized a series of DBO derivatives A1–23 containing amidine substituents at the C2 position of the bicyclic ring. These compounds, alone and in combination with meropenem, were tested against ten bacterial strains for their antibacterial activity in vitro. All compounds did not show antibacterial activity when tested alone (MIC >64 mg/L), however, they exhibited a moderate inhibition activity in the presence of meropenem by lowering its MIC values. The compound A12 proved most potent among the other counterparts against all bacterial species with MIC from E. coli strains with a MIC value of <0.125 mg/L.Keywords
All Related Versions
Funding Information
- Science and Technology Department of Ningxia Province (2018BCG01001)
This publication has 30 references indexed in Scilit:
- New β-Lactamase Inhibitors in the ClinicInfectious Disease Clinics of North America, 2016
- Ceftazidime/Avibactam and Ceftolozane/Tazobactam: Second-generation β-Lactam/β-Lactamase Inhibitor CombinationsClinical Infectious Diseases, 2016
- OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam ‘enhancer’Journal of Antimicrobial Chemotherapy, 2015
- New β‐lactam–β‐lactamase inhibitor combinations in clinical developmentAnnals of the New York Academy of Sciences, 2013
- Diazabicyclooctanes (DBOs): a potent new class of non-β-lactam β-lactamase inhibitorsCurrent Opinion in Microbiology, 2011
- Clavulanic acid: A reviewBiotechnology Advances, 2008
- A review of the antimicrobial activity of clavulanateJournal of Antimicrobial Chemotherapy, 2003
- Augmentin reconsideredDrug and Therapeutics Bulletin, 1996
- Conversion of ‘obstinate’ nitriles to amidines by Garigipati's reactionTetrahedron Letters, 1995
- Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coliAntimicrobial Agents and Chemotherapy, 1993